0001209191-12-035452.txt : 20120626 0001209191-12-035452.hdr.sgml : 20120626 20120626175418 ACCESSION NUMBER: 0001209191-12-035452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120625 FILED AS OF DATE: 20120626 DATE AS OF CHANGE: 20120626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUNDBERG MAGNUS CENTRAL INDEX KEY: 0001235944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 12928048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-06-25 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235944 LUNDBERG MAGNUS C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2012-06-25 4 M 0 5000 12.11 A 15616 D Common Stock 2012-06-25 4 S 0 5000 65.175 D 10616 D Stock Option (Right to Buy) 12.11 2012-06-25 4 M 0 5000 0.00 D 2004-06-09 2013-06-09 Common Stock 5000 0 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices between $64.90 and $65.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Warren DeSouza, Attorney-in-fact 2012-06-26